As of September 2019, Parkinson Canada and its partners are proud to support 30 new grants, fellowships, and student awards.
The new awards include:
Pilot Project Grants
New Investigator Awards
Basic Research Fellowships
Clinical Movement Disorders Fellowship
Graduate Student Awards
Financial support from individuals, corporations and foundations makes the Parkinson Canada Research Program possible. Funding for the Parkinson Canada Research Program is provided by Parkinson Canada, our regional partners and our research partners across the country.
Finding better treatments to learn more about the causes, progression, and complications of Parkinson’s.
Improving quality of life for people with Parkinson’s and their families so they can live their lives to the fullest, despite the challenges of this disease. This area of research spans a variety of health disciplines such as nursing, occupational therapy, speech language pathology and social work.
Building capacity among the next generation of Canadian researchers. We also fund specialized training for doctors in the diagnosis and management of the disease and other movement disorders so there will be more Parkinson’s specialists to provide high quality care.
Contributing on an international scale to the collective understanding of this complex disease and to the global search for a cure. Continued investments in research will produce more life-changing discoveries and bring us closer to a world without Parkinson’s disease.
Related Disorders, such as Multiple System Atrophy (MSA), Progressive Supranuclear Palsy (PSP) and other Parkinson’s conditions, are also funded by the Parkinson Canada Research Program.
Scientific Advisory Council
The Scientific Advisory Council (SAC) is a volunteer panel of experts which reviews funding applications to determine scientific excellence and relevance to Parkinson’s disease, providing the highest quality of objective adjudication.
Dr. Ron Postuma, Chair, Associate Professor of Neurology and Neurosurgery, Faculty of Medicine, McGill University; Staff neurologist, Montreal General Hospital, Researcher at the Research Institute of the McGill University Health Centre (MUHC) and at Sacré Coeur Hospital
Dr. Silke Appel-Cresswell, Assistant Professor, Medicine/Neurology, University of British Columbia; Clinician Scientist, Pacific Parkinson’s Research Centre and Djavad Mowafghian Centre for Brain Health
Dr. Frédéric Calon, Professor, Department of Pharmacy, Université Laval
Dr. Robert Chen, Professor of Medicine (Neurology), University of Toronto; Senior Scientist, Krembil Research Institute; Senior Scientist
Dr. Bin Hu, Professor, Departments of Clinical Neurosciences, Cell Biology & Anatomy, University of Calgary
Dr. Lorraine Kalia, Assistant Professor and Clinician-Scientist, Division of Neurology at University of Toronto; Neurologist, Movement Disorders Centre, Toronto Western Hospital
Dr. Wayne Martin, Professor, Division of Neurology, Movement Disorders Program, University of Alberta, Kaye Edmonton Clinic
Dr. Mario Masellis, Associate Scientist, Sunnybrook Health Institute; Assistant Professor, Neurology, Department of Medicine, University of Toronto
Dr. Abid Oueslati, Assistant Professor, Faculty of Medicine, Université Laval
Dr. Caroline Paquette, Assistant Professor, Department of Kinesiology and Physical Education, McGill University
Dr. Tamara Pringsheim, Associate Professor, with the Department of Clinical Neurosciences, Psychiatry, Pediatrics and Community Health Sciences, University of Calgary
Dr. Ekaterina Rogaeva, Professor, Department of Medicine, University of Toronto
Dr. Abbas Sadikot, Neurosurgeon, Montreal Neurological Institute, McGill University
Dr. Louis-Eric Trudeau, Professor, Department of Pharmacology, Faculty of Medicine, University of Montreal
Dr. Jean-François Trempe, Assistant Professor, Department of Pharmacology & Therapeutics, McGill University
Dr. Joel Watts, Assistant Professor, Department of Biochemistry, University of Toronto; Principal Investigator, Tanz Centre for Research in Neurodegenerative Diseases (CRND)
Research Policy Committee
The Research Policy Committee (RPC) provides funding allocation recommendations to the Parkinson Canada Board of Directors. The RPC also advises the Board on policies about the most effective means to promote research into the cause(s), management, and eventual cure of Parkinson’s disease.
The Research Policy Committee (RPC) and Scientific Advisory Council (SAC) are two separate volunteer committees. The chair of the SAC also serves on the RPC to ensure continuity.
Dr. Martin McKeown, Chair, RPC; Pacific Parkinson’s Research Institute/University of British Columbia Chair in Parkinson’s Research; Director, Pacific Parkinson’s Research Centre; Professor, Department of Medicine, University of British Columbia; Adjunct Professor, Department of Electrical and Computer Engineering, University of British Columbia
Dr. Ron Postuma, Chair, SAC; Associate Professor of Neurology and Neurosurgery, Faculty of Medicine, McGill University; Staff neurologist, Montreal General Hospital, Researcher at the Research Institute of the McGill University Health Centre (MUHC) and at Sacré Coeur Hospital
Dr. Wendy Horbay, Vice-Chair, Independent Heath Related Strategic Planning Consultant
Dr. Daniel Levesque, Professor, Faculté de Pharmacie, Université de Montréal
Dr. Julie Nantel, Associate professor, Faculty of Health Sciences, School of Human Kinetics, University of Ottawa
Dr. Angela Roberts, Speech Language Pathologist, Endowed Fellow in Care of the Aging, Lawson Health Research Institutes
Mr. John Parkhurst, Patient Advocate
Dr. Antonio Strafella, Canada Research Chair in Movement Disorders and Neuroimaging; Professor in the Dept. of Medicine (Division of Neurology) at the Toronto Western Hospital, University Health Network, University of Toronto; Senior Scientist in the Krembil Research Institute at the University Health Network; Scientist in the Research Imaging Centre at CAMH (Centre for Addiction Mental Health).
Connect With Us
Subscribe through email and social media to stay up to date on all news relating to Parkinson’s Disease, new research, and emerging treatments.
Committed to Canada
Since 1965, Parkinson Canada has worked to provide support services and education to people living with Parkinson’s disease, their families, and the health care professionals who treat them. We advocate on issues that affect the Parkinson’s community in Canada, and we aggressively fund innovative research for better treatments and a cure.
Parkinson Canada is a national registered charity accredited under the Imagine Canada Standards Program. We achieve our mission through the support of people like you.